A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)

NCT00644709 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.